UBS AM’s EyePoint Inc EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.93M Buy
149,861
+148,686
+12,654% +$2.22M ﹤0.01% 2055
2025
Q4
$21.5K Buy
+1,175
New +$16.7K ﹤0.01% 2728
2025
Q2
Sell
-96,811
Closed -$525K 2652
2025
Q1
$525K Buy
96,811
+6,462
+7% +$45.2K ﹤0.01% 2494
2024
Q4
$673K Buy
90,349
+21,719
+32% +$202K ﹤0.01% 2497
2024
Q3
$548K Sell
68,630
-10,616
-13% -$93.2K ﹤0.01% 2617
2024
Q2
$689K Buy
79,246
+69,146
+685% +$966K ﹤0.01% 2540
2024
Q1
$209K Buy
+10,100
New +$250K ﹤0.01% 2458

Other funds holding EYPT

UBS AM's EYPT Position: Q1 2026 in Review

UBS AM increased its EyePoint Inc (EYPT) stake by 12,654% in Q1 2026, buying an estimated $2.22M and bringing the position to 149,861 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2055.

UBS AM first reported a position in EYPT in Q1 2024 and has held it in 7 quarters since. 188 funds tracked by Wall St. Rank hold EYPT as of Q1 2026.

  • UBS AM held 149,861 shares of EyePoint Inc worth $1.93M as of Q1 2026.
  • UBS AM bought 148,686 EyePoint Inc shares in Q1 2026, an estimated $2.22M.
  • EyePoint Inc made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2055 holding.
  • UBS AM first reported a position in EyePoint Inc in Q1 2024 and has held it in 7 quarters since.
  • 188 funds tracked by Wall St. Rank held EyePoint Inc as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.